Plexus Corp. (NASDAQ:PLXS – Get Free Report) has been given an average recommendation of “Buy” by the eight research firms that are currently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $276.86.
A number of equities analysts recently commented on PLXS shares. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective for the company in a research note on Friday, July 31st. Weiss Ratings raised Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Wall Street Zen upgraded Plexus from a “hold” rating to a “buy” rating in a report on Sunday, October 4th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $310.00 price target on shares of Plexus in a research report on Friday, August 14th.
Get Our Latest Analysis on PLXS
Insider Buying and Selling
In related news, Director Karen Rapp sold 500 shares of the firm’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $240.87, for a total transaction of $120,435.00. Following the sale, the director owned 7,535 shares of the company’s stock, valued at $1,814,955.45. This trade represents a 6.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Todd Kelsey sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $242.41, for a total value of $363,615.00. Following the sale, the chief executive officer directly owned 64,388 shares in the company, valued at approximately $15,608,295.08. The trade was a 2.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,500 shares of company stock worth $1,960,520 in the last three months. 1.78% of the stock is owned by insiders.
Institutional Trading of Plexus
Hedge funds have recently modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Plexus during the 2nd quarter valued at $32,000. Kilter Group LLC acquired a new stake in shares of Plexus in the 2nd quarter worth $40,000. Pension & Wealth Management Advisors Inc. acquired a new stake in shares of Plexus in the 3rd quarter worth $45,000. Integrated Wealth Concepts LLC acquired a new stake in shares of Plexus in the 2nd quarter worth $51,000. Finally, Persistent Asset Partners Ltd purchased a new position in Plexus during the 2nd quarter worth $71,000. 94.45% of the stock is owned by hedge funds and other institutional investors.
Plexus Trading Up 0.6%
NASDAQ PLXS opened at $236.44 on Friday. Plexus has a one year low of $132.03 and a one year high of $307.06. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49. The company has a market capitalization of $6.33 billion, a price-to-earnings ratio of 34.65 and a beta of 0.88. The company’s 50-day simple moving average is $252.16 and its two-hundred day simple moving average is $258.30.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping the consensus estimate of $2.13 by $0.19. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The firm had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same quarter in the prior year, the company earned $1.64 EPS. The company’s revenue was up 28.2% compared to the same quarter last year. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Equities analysts forecast that Plexus will post 7.13 EPS for the current fiscal year.
About Plexus
Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.
Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.
Featured Stories
- Five stocks we like better than Plexus
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
